Table 2.
Median cumulative doses and duration of bisphosphonate therapy for the 33 studied patients with multiple mieloma
| Pamidronate | Zoledronate | Clodronate | |
|---|---|---|---|
| Number of patientsa | 33 (100%) | 04 (12.1%) | 03 (9.1%) |
| Cumulative dosisb (mg) | 993 (60–9.000) | 66 (52–120) | 15000 (4.500–43.500) |
| Durationb (months) | 13 (2–100) | 16 (13–30) | 10 (3–29) |
a
Four individuals had history of pamidronate and zoledronate exposition, and three individuals had history of pamidronate and clodronate exposition.
b
Median (minimum–maximum).mg=milligrams.